MedTrace Logo

Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program

NCT03787966 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-11-19

No results posted yet for this study

Summary

The aim of this study is to determine if therapeutic exercise before anticancer treatment will mitigate the onset or extent of cardiotoxicity comparing to therapeutic exercise performed during anticancer treatment.

Conditions

  • Breast Neoplasms

Interventions

OTHER

ATOPE-B

Patients will perform therapeutic exercise before medical treatment and will follow the usual care after medical treatment.

OTHER

ATOPE-I

Patients will follow usual care before medical treatment and will perform therapeutic exercise after medical treatment.

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Irene Cantarero-Villanueva, PhD · Physical Therapy Deparment, Faculty of Health Sciences, University of Granada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2025-06-15
Completion
2025-11-14

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03787966 on ClinicalTrials.gov